COMMUNIQUÉS West-GlobeNewswire

Sun Biopharma, Inc. Presents Poster at Pancreasfest in Pittsburgh, Pa.
27/07/2018
Results of Phase 1 Safety Study of SBP-101 for Pancreatic Ductal Adenocarcinoma PancreasFest is an International Conference of Physicians and Scientists Focused on Pancreatic Diseases MINNEAPOLIS, MN, July 27, 2018 ( [...]
Delcath Amends Phase 3 Ocular Melanoma Trial Protocol
27/07/2018
Revision to Nonrandomized (Single Arm) Study Reduces Trial Size Enrollment Requirement Enrollment Anticipated to be Completed by First Half 2019 NEW YORK, July 27, 2018 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (OTCQB: [...]
Tonix Pharmaceuticals Announces Outcome of Interim Analysis for Phase 3 HONOR Study of Tonmya® in Military-Related PTSD
27/07/2018
HONOR Study will Stop due to Inadequate Separation from Placebo at Week-12 Results at Week-4 Demonstrated Meaningful Clinical Improvement Company Plans to Meet with FDA to Discuss Next Steps for this Breakthrough [...]
Samumed Presents Positive Preclinical Data on SM07883 at 2018 Alzheimer’s Association International Conference® (AAIC®)
27/07/2018
Data supports SM07883 as a potential treatment for chronic tauopathies such as Alzheimer’s disease Company expects SM07883 to enter first-in-man studies in fall 2018 SAN DIEGO, July 27, 2018 (GLOBE NEWSWIRE) -- Samumed [...]
eFFECTOR Initiates Dosing of eFT508 (tomivosertib) in a Phase 2 Add-on (CPI-A) Trial in Combination with Checkpoint Inhibitors to Treat Patients with Insufficient Response to Checkpoint Inhibitors Alone
27/07/2018
SAN DIEGO, July 27, 2018 (GLOBE NEWSWIRE) -- eFFECTOR Therapeutics, Inc., a leader in the development of selective translation regulators (STRs) for the treatment of cancer, today announced that it has dosed the first [...]
BeiGene Announces Proposed Hong Kong Initial Public Offering and Global Offering
27/07/2018
CAMBRIDGE, Mass. and BEIJING, China, July 27, 2018 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ:BGNE), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative molecularly-targeted [...]
Resonant to Host Second Quarter 2018 Financial Results Conference Call on Thursday, August 9th at 1:30 p.m. Pacific Daylight Time
27/07/2018
GOLETA, Calif., July 27, 2018 (GLOBE NEWSWIRE) -- Resonant Inc. (NASDAQ:RESN), a leader in transforming the way radio frequency, or RF, front-ends are being designed and delivered for wireless devices, announced it will [...]
Auxly Announces Listing of Warrants
27/07/2018
VANCOUVER, British Columbia, July 27, 2018 (GLOBE NEWSWIRE) -- Auxly Cannabis Group Inc. (TSX.V - XLY) (the " Company ") is pleased to announce that it has received the approval of the TSX Venture Exchange (" TSXV ") [...]
CrownBio Expands Novel Humanized Models for Targeted Immunotherapy Development to San Diego, CA Research Center
27/07/2018
Humanized Model Expansion Program begins with PD-1, CTLA-4, and CD137 Models SAN DIEGO, July 27, 2018 (GLOBE NEWSWIRE) -- Crown Bioscience , a global drug discovery and development services company providing [...]
Status of Orphan designation of Apealea in the European Union
27/07/2018
Oasmia Pharmaceutical AB (NASDAQ: OASM) herewith announces that Apealea was designated as an orphan medicine by the European Commission in 2006 and alongside the procedure of the application for assessing a Market [...]
Chi-Med Reports 2018 Interim Results and Updates Shareholders on Key Clinical Programs
27/07/2018
LONDON, July 27, 2018 (GLOBE NEWSWIRE) -- Hutchison China MediTech Limited (“ Chi-Med ”) (AIM:HCM) (Nasdaq:HCM) today announces its unaudited financial results for the six months ended June 30, 2018 and updates [...]
DBV Technologies Reports June 30, 2018 Cash Position
27/07/2018
Montrouge, France, July 27, 2018 DBV Technologies Reports June 30, 2018 Cash Position DBV Technologies (Euronext: DBV - ISIN: FR0010417345 - Nasdaq Stock Market: DBVT) today announced its cash and cash equivalents as of [...]
DBV Technologies publie sa position de trésorerie au 30 Juin 2018
27/07/2018
Montrouge, France, le 27 Juillet (7H30 CEST), 2018 DBV Technologies publie sa position de trésorerie au 30 Juin 2018 DBV Technologies, (Euronext: DBV - ISIN : FR0010417345 - NASDAQ : DBVT), société biopharmaceutique [...]
Lefebvre family inspired by Terry Fox while walking across Canada for cancer research
27/07/2018
HALLVILLE, Ontario, July 26, 2018 (GLOBE NEWSWIRE) -- On May 1, Jimmy Lefebvre and his family left his parents’ home in Grande Prairie, Alberta to embark on a 5,700-kilometre walk across Canada in honour of his late [...]
Nabriva Therapeutics Announces Pricing of Public Offering of Ordinary Shares of Approximately $50 Million
27/07/2018
DUBLIN, Ireland and KING OF PRUSSIA, Pa., July 26, 2018 (GLOBE NEWSWIRE) -- Nabriva Therapeutics plc (NASDAQ:NBRV) today announced the pricing of its underwritten public offering of 18,181,818 ordinary shares at a [...]
Scythian Biosciences Announces Director Resignation
27/07/2018
TORONTO, July 26, 2018 (GLOBE NEWSWIRE) -- Scythian Biosciences Corp. (to be renamed Sol Global Investments Corp.) (the " Company " or “ Scythian ”) (TSXV:SCYB) (Frankfurt:9SB) (OTC – Nasdaq Intl:SCCYF) today announced [...]
Adherium Receives Additional U.S. FDA 510(k) Clearance, Setting in Motion a Full U.S. Consumer Launch of the Hailie™ Solution
27/07/2018
SAN MATEO, Calif., July 26, 2018 (GLOBE NEWSWIRE) -- Adherium (ASX:ADR), an award-winning digital health platform that improves medication adherence, patient outcomes and engagement, today announced the U.S. Food and [...]
National Research Corporation to Broadcast its 2018 Second Quarter Conference Call Live on the Internet
26/07/2018
Lincoln, Nebraska, July 26, 2018 (GLOBE NEWSWIRE) -- National Research Corporation (NASDAQ/:NRC) today announced that it will provide an online web simulcast of its 2018 second quarter earnings conference call on [...]
Dyadic International to Announce Second Quarter 2018 Financial Results and Host Conference Call on Thursday, August 9, 2018
26/07/2018
JUPITER, Fla., July 26, 2018 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”) (OTCQX:DYAI), a global biotechnology company focused on further improving and applying its proprietary C1 expression system to help [...]

Pages